Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEARTLAND: Viekira Pak in Real World HCV Patients
NCT03710252Phase 4Completed
- Sponsor
- American Research Corporation
- Start
- Mar 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of Viekira Pak in hepatitis C (HCV), sponsored by American Research Corporation. Primary endpoint: Sustained Virologic Response 12 weeks post-treatment. Started Mar 2016; status: completed.
02
Drugs
Viekira Pak
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03710252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03710252.